Who Owns BioMarin Pharmaceutical Inc
Every manager with more than $100m in listed equities files a 13F each quarter naming what they hold. These are the ones reporting a position in BioMarin Pharmaceutical Inc.
Who crossed 5% of BMRN →Positions as of 2026-09-30
Largest first. The move is against the previous quarter that manager filed, not the previous calendar quarter.
| Manager | Value |
|---|---|
| INSPIRION WEALTH ADVISORS, LLCCOM9.2K shtrimmed | $554K |
| Everhart Financial Group, Inc.COM8.8K shadded | $529.6K |
| Farther Finance Advisors, LLCStock8.5K shadded | $509.3K |
| Central Pacific Bank - Trust DivisionCOM5.4K shheld | $321K |
| Wedmont Private CapitalCOM4K shtrimmed | $222.2K |
| GAMMA Investing LLCCommon Stock3.6K shadded | $218.5K |
| INSPIRION WEALTH ADVISORS, LLCCOM500 shtrimmed | $30K |
| MassMutual Private Wealth & Trust, FSBCommon / Ordinary Stock449 shtrimmed | $26.9K |
| TOTH FINANCIAL ADVISORY CORPCOM287 shadded | $17.2K |
| ELEVATION WEALTH PARTNERS, LLCCOM47 shheld | $2.8K |
| CoreCap Advisors, LLCStock23 shheld | $1.4K |
| Marquette Asset Management, LLCCOM16 shheld | $960 |
| Trust CoStock1 shheld | $60 |
Source: quarterly 13F filings, via EDGAR. A 13F reports positions by CUSIP alone; each CUSIP here has been confirmed against OpenFIGI rather than matched by name, because a name match would attribute one company's shareholders to another. Positions are as of quarter end and can be months old by the time they are filed, and 13F covers long equity positions only — not shorts, and not most debt. The summed value is what these filers reported, not the company's institutional ownership.
More on BMRN
Follow BioMarin Pharmaceutical Inc (BMRN) by email
New trades in BioMarin Pharmaceutical Inc (BMRN) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.